πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6251861

Treatment of cerebral infarction using cyclic hexapeptides

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251396

Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic pr

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6248528

Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders

The Regents of the University of California Β· Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245362

Medication for treatment of viral disease based on active agents of plant hypericum (St. J

Dreluso Pharmazeutika Dr. Elten & Sohn GmbH Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6242482

Prostaglandin compounds and derivatives thereof, compositions containing the same and meth

United Therapeutics Corporation Β· Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6242473

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. Β· Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6228873

Method for enhancing outflow of aqueous humor in treatment of glaucoma

The Regents of the University of California Β· Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6218437

Treatment and prevention of hepatic disorders

The Regents of the University of California Β· Granted Tue Apr 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210680

Method for the prevention and treatment of chronic venous insufficiency

Univera Pharmaceuticals, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6207159

Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

The Regents of the University of California Β· Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6204245

Treatment of narcolepsy with immunosuppressants

The Regents of the University of California Β· Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6200597

Formulation and use of carotenoids in treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6197926

Methods for treatment of diabetes using peptide analogues of insulin

Neurocrine Biosciences, Inc. Β· Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6197345

Thrombolytic agents and methods of treatment for thrombosis

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6187814

Treatment of skin conditions with FXR activators

The Regents of the University of California Β· Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6187296

Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6184215

Treatment of skin conditions with oxysterol activators of LXR.alpha.

The Regents of the University of California Β· Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6171788

Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders

The Regents of the University of California Β· Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6166079

DFMO for the treatment or prevention of cervical intraepithelial neoplasia

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6166008

Treatment of schizophrenia with ampakines and neuroleptics

The Regents of the University of California Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165484

EDTA and other chelators with or without antifungal antimicrobial agents for the preventio

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6162432

Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6159958

Treatment or prophylaxis of retinal pathology and spinal cord injury

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6156321

Tissue factor methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired